Efficacy and safety of arbidol (umifenovir) in patients with COVID‐19: A systematic review and meta‐analysis
Abstract Objective To provide the latest evidence for the efficacy and safety of arbidol (umifenovir) in COVID‐19 treatment. Methods A literature systematic search was carried out in PubMed, Cochrane Library, Embase, and medRxiv up to May 2021. The Cochrane risk of bias tool and Newcastle–Ottawa sca...
Saved in:
| Main Authors: | Behnam Amani, Bahman Amani, Sara Zareei, Mahsa Zareei |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-12-01
|
| Series: | Immunity, Inflammation and Disease |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/iid3.502 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Relationship between novel coronavirus pneumonia (NCP) and eyes and relevant protective suggestions
by: Wei DING, et al.
Published: (2020-04-01) -
Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture
by: Ya-Nan Zhang, et al.
Published: (2020-01-01) -
Adolescents' Sexual Health During the COVID‐19 Outbreak: A Systematic Review
by: Elahe Ahmadnia, et al.
Published: (2025-05-01) -
Umifenovir (Arbidol) Efficacy in Experimental Mixed Viral and Bacterial Pneumonia of Mice
by: I. A. Leneva, et al.
Published: (2020-05-01) -
Analysis of epidemic characteristics of novel coronavirus pneumonia in Henan Province
by: Rui-Jing QIN, et al.
Published: (2020-04-01)